Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosis
Carmen Herranz(Bellvitge University Hospital), Aslihan Ugun‐Klusek(Nottingham Trent University), Aleix Noguera‐Castells(Universitat de Vic - Universitat Central de Catalunya), August Vidal(Bellvitge University Hospital), Ana Montes‐Worboys(Universitat de Barcelona), Susana Gómez‐Ollés(Vall d'Hebron Hospital Universitari), Rosalía Laporta(Hospital Universitario Puerta de Hierro Majadahonda), Berta Sáez(Vall d'Hebron Hospital Universitari), Simon R. Johnson(Nottingham University Hospitals NHS Trust), Chiara Gorrini(Princess Margaret Cancer Centre), Enrique Lastra(Hospital Universitario de Burgos), Carlos Machahua(University of Bern), Roser Guiteras(Bellvitge University Hospital), Christophe Bontoux(Sorbonne Université), José C. Perales(Universitat de Barcelona), Harilaos Filippakis(Brigham and Women's Hospital), Mario Mancino(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Francesc Viñals(Bellvitge University Hospital), Luís Palomero(Institut d'Investigació Biomédica de Bellvitge), Tamara Alonso(Hospital Universitario de La Princesa), Josep M. Cruzado, Ana I. Extremera(Bellvitge University Hospital), Marian J.R. Quanjel(St. Antonius Ziekenhuis), Alexandra Baiges(Bellvitge University Hospital), Jaume Bordas-Martínez(Instituto de Salud Carlos III), Piedad Ussetti, Daniel Cuadras(Sant Joan de Déu Research Foundation), Claudia Valenzuela(Hospital Universitario de La Princesa), Antonio Gómez(Universitat de Vic - Universitat Central de Catalunya), Roderic Espín(Bellvitge University Hospital), Razqallah Hakem(University Health Network), José Antonio Rodríguez-Portal(Instituto de Salud Carlos III), Francesca Mateo(Institut d'Investigació Biomédica de Bellvitge), Eva Revilla‐López(Vall d'Hebron Hospital Universitari), Joanne J. van der Vis(St. Antonius Ziekenhuis), Gorka Ruíz de Garibay(Bellvitge University Hospital), Raül Rigo‐Bonnin(Bellvitge University Hospital), Jordi Capellades(Instituto de Salud Carlos III), Julio Ancochea(Hospital Universitario de La Princesa), Javier A. Menéndez(Institut Català d'Oncologia), Eline Blommaert(Bellvitge University Hospital), Concettina La Motta(University of Pisa), Alexandra Junza(Instituto de Salud Carlos III), Xiaohu Zhang(Soochow University), S. Miller(Nottingham University Hospitals NHS Trust), Nadia García(Institut d'Investigació Biomédica de Bellvitge), Antoni Xaubet(Hospital Clínic de Barcelona), Marc Ferrer(National Institute of Biomedical Innovation, Health and Nutrition), Coline H.M. van Moorsel(Inserm), Álvaro Lahiguera(Bellvitge University Hospital)
Cited by 21
Related Papers
Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
|Cancer Cell|2009|2.3k
<i>MUC5B</i> Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease
|New England Journal of Medicine|2018|501
Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells
|Journal of Clinical Investigation|2012|462
COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration
|Nephrology Dialysis Transplantation|2020|411
Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management
|American Journal of Respiratory and Critical Care Medicine|2016|366